Representative Lisa C. McClain (R-Michigan) recently bought shares of Align Technology, Inc. (NASDAQ:ALGN). In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Align Technology stock on August 4th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $50,001 – $100,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 8/28/2025.
- Purchased $1,001 – $15,000 in shares of ACI Worldwide (NASDAQ:ACIW) on 8/19/2025.
- Purchased $1,001 – $15,000 in shares of HCA Healthcare (NYSE:HCA) on 8/19/2025.
- Sold $1,001 – $15,000 in shares of Amedisys (NASDAQ:AMED) on 8/18/2025.
- Purchased $1,001 – $15,000 in shares of Kite Realty Group Trust (NYSE:KRG) on 8/13/2025.
- Sold $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 8/13/2025.
- Purchased $1,001 – $15,000 in shares of JD.com (NASDAQ:JD) on 8/13/2025.
- Sold $1,001 – $15,000 in shares of Trade Desk (NASDAQ:TTD) on 8/13/2025.
- Sold $1,001 – $15,000 in shares of US Foods (NYSE:USFD) on 8/13/2025.
- Purchased $1,001 – $15,000 in shares of Agree Realty (NYSE:ADC) on 8/13/2025.
Align Technology Trading Down 0.9%
NASDAQ ALGN opened at $131.39 on Monday. The stock’s 50 day moving average is $153.82 and its two-hundred day moving average is $168.37. The company has a market capitalization of $9.52 billion, a price-to-earnings ratio of 22.16, a PEG ratio of 1.48 and a beta of 1.65. Align Technology, Inc. has a 1-year low of $127.70 and a 1-year high of $260.35.
Align Technology announced that its board has authorized a share repurchase plan on Tuesday, August 5th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to purchase up to 2% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.
Institutional Trading of Align Technology
Institutional investors have recently bought and sold shares of the business. Rothschild Investment LLC grew its holdings in Align Technology by 140.3% during the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 87 shares during the period. True Wealth Design LLC grew its holdings in Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 153 shares during the period. Compagnie Lombard Odier SCmA acquired a new stake in Align Technology during the 1st quarter worth $32,000. Cromwell Holdings LLC grew its holdings in Align Technology by 2,900.0% during the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 174 shares during the period. Finally, Center for Financial Planning Inc. acquired a new stake in Align Technology during the 1st quarter worth $35,000. Institutional investors and hedge funds own 88.43% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on ALGN. Stifel Nicolaus decreased their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company cut their target price on shares of Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Zacks Research cut shares of Align Technology from a “hold” rating to a “strong sell” rating in a research note on Monday, September 1st. Evercore ISI lifted their target price on shares of Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a research note on Wednesday, July 9th. Finally, Piper Sandler cut their target price on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $215.00.
Get Our Latest Stock Report on Align Technology
Insider Buying and Selling
In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of the stock in a transaction on Friday, August 1st. The stock was purchased at an average price of $131.49 per share, with a total value of $996,168.24. Following the acquisition, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.66% of the company’s stock.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Further Reading
- Five stocks we like better than Align Technology
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Overlooked Value Stocks Set to Surge as Rates Drop
- How is Compound Interest Calculated?
- Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
- How to Buy Cheap Stocks Step by Step
- After the Fed’s Rate Cut, PNC Could See a Mortgage Refinance Boom
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.